Results 21 to 30 of about 163,167 (287)

Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections

open access: yesAntibiotics, 2022
The treatment of eye infections is very different than treating other body infections that require systemic anti-infectives. Endophthalmitis, keratitis, conjunctivitis, and other ocular infections are treated with direct injection and with topical drops ...
Regis P. Kowalski   +3 more
doaj   +1 more source

Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development

open access: yesInfectious Disease Reports, 2017
There is now global recognition that antibiotic resistance is an emerging public health threat. Policy initiatives are underway to provide concrete suggestions for overcoming important obstacles in the fight against antibiotic resistance, like the ...
Ursula Theuretzbacher   +2 more
doaj   +1 more source

Frontiers in Anti-infective Agents [PDF]

open access: yes, 2022
Ocular drug targeting is one of the most interesting and challenging research topics due to the presence of natural barriers of the eye that attract pharmaceutical technologists.
Erginer, Yıldız   +3 more
core  

Topical applications of ozone and ozonated oils as anti-infective agents: an insight into the patent claims [PDF]

open access: yes, 2009
Orthodox medicine has been very active in the field of topical anti-infective agents and current chemotherapy has procured valid antibiotics, antivirals, vaccines, antibodies, and antiparasitic drugs to be parenterally and/or topically used.
Bocci V., Travagli V., Zanardi I.
core   +1 more source

Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. [PDF]

open access: yesClin Microbiol Rev, 2013
For the optimization of dosing regimens of anti-infective agents, it is imperative to have a good understanding of pharmacokinetics (PK) and pharmacodynamics (PD). Whenever possible, drug efficacy needs to be related to unbound concentrations at the site
Gonzalez D, Schmidt S, Derendorf H.
europepmc   +3 more sources

Limited-sampling strategies for anti-infective agents: systematic review. [PDF]

open access: yesCan J Hosp Pharm, 2009
Background: Area under the concentration–time curve (AUC) is a pharmacokinetic parameter that represents overall exposure to a drug. For selected anti-infective agents, pharmacokinetic–pharmacodynamic parameters, such as AUC/MIC (where MIC is the minimal
Sprague DA, Ensom MH.
europepmc   +3 more sources

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

open access: yesJournal of Pharmaceutical Policy and Practice, 2018
Background Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients.
Christine Årdal   +6 more
doaj   +1 more source

Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey

open access: yesBMJ Open, 2019
Objectives The 23-valent pneumococcal polysaccharide vaccine (PPSV23) was included in Japan’s national immunisation programme for older adults in 2014.
Yoshitaka Murakami   +5 more
doaj   +1 more source

Phytomedicinal properties of Hygrophila schulli (Neeramulliya) [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
Hygrophila schulli which is known as “Neermulli’’ in the vernacular is an herbaceous plant native to Sri Lanka. Ancient medicinal literature suggests the use of H.
Malshani Nissanka   +5 more
doaj   +1 more source

Reducing self--medication with anti-infective agents in Lagos, nigeria: a community-based intervention study [PDF]

open access: yes, 2019
Background: Self-medication with anti-infective agents is a global public health concern particularly in the developing countries. In this study, the rate and pattern of self-medication with anti-infective agents and effectiveness of an educational ...
Oreagba, I.A.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy